Microbix Biosystems Inc.
MBXBF
$0.2992
$0.00511.73%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.43% | 24.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.43% | 24.80% | |||
| Cost of Revenue | -21.48% | 23.42% | |||
| Gross Profit | 5.97% | 25.96% | |||
| SG&A Expenses | -1.40% | 7.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.45% | 14.45% | |||
| Operating Income | 32.99% | 331.37% | |||
| Income Before Tax | 41.32% | 140.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 89.65% | 79.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 89.65% | 79.03% | |||
| EBIT | 32.99% | 331.37% | |||
| EBITDA | 25.32% | 74.83% | |||
| EPS Basic | 87.50% | 84.62% | |||
| Normalized Basic EPS | 12.00% | 733.33% | |||
| EPS Diluted | 79.17% | 84.62% | |||
| Normalized Diluted EPS | 12.00% | 733.33% | |||
| Average Basic Shares Outstanding | -1.03% | -0.39% | |||
| Average Diluted Shares Outstanding | -1.10% | -0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
